Sharps Compliance Authorizes $3.0 Million Stock Repurchase Program

Sharps Compliance Authorizes $3.0 Million Stock Repurchase Program

HOUSTON, Jan. 7, 2013 (GLOBE NEWSWIRE) -- Sharps Compliance Corp.
(Nasdaq:SMED) ("Sharps" or the "Company"), a leading full-service provider of
solutions for the cost-effective management of medical waste, used healthcare
materials and unused dispensed medications, announced today that its Board of
Directors has approved a stock repurchase program effective January 3, 2013,
authorizing the Company to repurchase in the aggregate up to $3 million of its
outstanding common stock over a two-year period. 

David P. Tusa, President and CEO of Sharps Compliance commented, "The Board's
decision for a stock repurchase program affirms the confidence we have in the
Company's strategic direction and market opportunities.With our solid balance
sheet, this repurchase authorization offers an opportunity to return value to
shareholders while retaining the flexibility to fund our growth."

The shares would be purchased from time to time on the open market or in
privately negotiated transactions, at the Company's discretion, in each case,
in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as
amended, subject to market and business conditions, applicable legal
requirements, explicit black-out dates and other factors. The purchases will
be funded using the Company's available cash balances and cash generated from
operations.The program does not obligate the Company to acquire any
particular amount of common stock and may be modified, suspended or terminated
at any time at the Company's discretion in accordance with Rule 10b-18.

About Sharps Compliance Corp.

Headquartered in Houston, Texas, Sharps Compliance is a leading full-service
provider of solutions for the cost-effective management of medical waste, used
healthcare materials and unused dispensed medications.Its strategy is to
capture a large part of the estimated $3.8 billion untapped market for its
solutions by targeting the major agencies that are interrelated with this
medical waste stream, including pharmaceutical manufacturers, home healthcare
providers, retail pharmacies and clinics, the U.S. government and the
professional market which is comprised of physicians, dentists and veterinary
practices.As a fully integrated medical waste management company providing
customer solutions and services, the Company's solid business model, which
provides strong margins and significant operating leverage, combined with its
early penetration into emerging markets, uniquely positions it for strong
future growth.The Company's flagship product, the Sharps® Recovery System™ is
a comprehensive solution for the containment, transportation, treatment and
tracking of medical waste and used healthcare materials.The Company's
TakeAway Environmental Return System™ is designed for individual consumers,
retail or mail-order pharmacies, communities and facilities including assisted
living, long-term care and correction operations to facilitate the proper
disposal of unused dispensed medications.The Complete Needle Collection &
Disposal System™ is a safe, easy-to-use and cost-effective solution designed
for self-injecting consumers and includes the Company's containment,
packaging, return shipping via the U.S. Postal Service, tracking and
treatment.

The Company has partnered with Daniels Sharpsmart in a joint marketing
alliance to serve the entire U.S. medical waste market, offering customers a
blended product portfolio to effectively target healthcare customers with
multi-site and multi-size locations.The alliance also enables a team effort
for cross selling each company's capabilities where best suited.

More information on the Company and its products can be found on its website
at: www.sharpsinc.com

Safe Harbor Statement

The information made available in this press release contains certain
forward-looking statements which reflect Sharps Compliance Corp.'s current
view of future events and financial performance.Wherever used, the words
"estimate", "expect", "plan", "anticipate", "believe", "may" and similar
expressions identify forward-looking statements.Any such forward-looking
statements are subject to risks and uncertainties and the company's future
results of operations could differ materially from historical results or
current expectations.Some of these risks include, without limitation, the
company's ability to educate its customers, development of public awareness
programs to educate the identified consumer, customer preferences, the
Company's ability to scale the business and manage its growth, the degree of
success the Company has at gaining more large customer contracts, managing
regulatory compliance and/or other factors that may be described in the
company's annual report on Form 10-K, quarterly reports on Form 10-Q and/or
other filings with the Securities and Exchange Commission.Future economic and
industry trends that could potentially impact revenues and profitability are
difficult to predict.The Company assumes no obligation to publicly update or
revise its forward-looking statements even if experience or future changes
make it clear that any projected results express or implied therein will not
be realized.

CONTACT: For more information contact:
         Diana P. Diaz
         Sharps Compliance Corp.
         Vice President and Chief Financial Officer
         Phone: (713) 660-3547
         Email: ddiaz@sharpsinc.com
        
         Deborah K. Pawlowski
         Kei Advisors LLC
         Investor Relations
         Phone: (716) 843-3908
         Email: dpawlowski@keiadvisors.com

Sharps Compliance, Inc. Logo